Immunology/Inflammation

The adaptive immune system consists of B and T lymphocytes which mediate humoral immunity (e.g. antibody response) and cell-mediated immunity, respectively. B cell receptor and T cell receptor signaling is responsible for activation of Src family tyrosine kinases, such as Blk, Fyn, and Lyn in B cells and Fyn and Lck in T cells, resulting phosphorylation of the receptor-associated ITAM motifs. Phosphorylated ITAMs serve as the docking sites for Syk family tyrosine kinases, e.g. Syk in B cells and Zap-70 in T cells. Activated Syk kinases then propagate the signals via phosphorylation of downstream proteins. Furthermore, lymphocyte receptor signaling facilitates B and T cell development, differentiation, proliferation and survival.
-   A3248 BMS345541 hydrochlorideTarget: IKKSummary: IKK inhibitor,highly selective A3248 BMS345541 hydrochlorideTarget: IKKSummary: IKK inhibitor,highly selective
-   A9920 Pam3CSK4 A9920 Pam3CSK4
-   A5384 ZileutonSummary: 5-lipoxygenase (5-LOX) inhibitor, orally active A5384 ZileutonSummary: 5-lipoxygenase (5-LOX) inhibitor, orally active
-   C6596 Emeramide C6596 Emeramide
-   C3973 MusconeSummary: anti-inflammatory effects C3973 MusconeSummary: anti-inflammatory effects
-   C4277 ML351Summary: human reticulocyte 15-LO-1 inhibitor C4277 ML351Summary: human reticulocyte 15-LO-1 inhibitor
-   B1969 MesalamineSummary: IKK inhibitor B1969 MesalamineSummary: IKK inhibitor
-   B1931 Dimethyl FumarateSummary: nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator B1931 Dimethyl FumarateSummary: nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator
-   B3425 Y-320Summary: immunomodulator B3425 Y-320Summary: immunomodulator
-   C6861 Syringaldehyde C6861 Syringaldehyde
